False lumen patency status and outcomes after endovascular repair of uncomplicated chronic type B dissection.
Minjian KongMing NiXian ZhuJianfang QianQunjun DuanJiangwei SongZhanzeng FengAiqiang DongPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2022)
TEVAR is an effective and safe treatment for uncomplicated cTBAD and has a low mortality rate. Thoracic FLCT is associated with less reintervention, but overall survival is not impacted by this difference. Patients treated with TEVAR without certain risk factors can have a good prognosis.